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strategies are needed for improving early disease 
detection, monitoring disease progression, and opti-
mizing the effi cacy of therapeutic ALS drug trials. 
Improved prediction accuracy of bulbar decline is 
also critical for clinical care because decisions regard-
ing communication intervention and palliative care 
are most effective when made prior to the loss of 
speech intelligibility (4). 
 A signifi cant obstacle, however, has been the 
logistical diffi culties posed by the inaccessibility 
and complexity of the bulbar apparatus. Although 
advanced instrumentation-based methods of bulbar 
assessment exist (5), most are designed for the 
assessment of speech production and remain unfa-
miliar to neurologists or other members of the 
ALS clinical team. Moreover, their reliability, valid-
ity, and responsiveness to bulbar motor deterioration 
are not well established. 
 Bulbar motor assessment in ALS: Challenges 
and future directions
 Progressive bulbar motor deterioration as a result of 
amyotrophic lateral sclerosis (ALS) leads to the 
eventual impairment of speech and swallowing func-
tion. At time of diagnosis, up to 30% of patients with 
ALS present with bulbar symptoms (1). Regardless 
of the site of onset, most patients with ALS will expe-
rience bulbar symptoms, which signifi cantly impact 
the quality of life and shorten survival (2,3). Despite 
these devastating consequences, no standardized 
diagnostic procedure for assessing bulbar dysfunc-
tion in ALS exists, and adequate objective markers 
of bulbar deterioration have yet to be identifi ed. 
Consequently, little is known about the natural his-
tory of bulbar deterioration, and clinicians invariably 
fi nd it challenging to predict the rate of speech and 
swallowing decline. Objective bulbar assessment 
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 Abstract 
 Bulbar motor deterioration due to amyotrophic lateral sclerosis (ALS) leads to the eventual impairment of speech and 
swallowing functions. Despite these devastating consequences, no standardized diagnostic procedure for assessing bulbar 
dysfunction in ALS exists and adequate objective markers of bulbar deterioration have not been identifi ed. In this paper, 
we consider objective measures of speech motor function, which show promise for forming the basis of a comprehensive, 
quantitative bulbar motor assessment in ALS. These measures are based on the assessment of four speech subsystems: 
respiratory, phonatory, articulatory, and resonatory. The goal of this research is to design a non-invasive, comprehensive 
bulbar motor assessment instrument intended for early detection, monitoring of disease progression, and clinical trial 
application. Preliminary data from an ongoing study of bulbar motor decline are presented, which demonstrate the potential 
clinical effi cacy of the speech subsystem approach. 
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 Neurologic examination and basic speech test-
ing have been components of the standard bulbar 
assessment battery for decades, yet these assess-
ments appear to be insensitive to the early phases 
of bulbar deterioration. Numerous studies have 
demonstrated, for example, that bulbar motor dys-
function occurs prior to perceived changes in speech 
intelligibility (4,6 – 11). Speaking rate, as measured 
in words per minute (wpm), has been observed to 
decline prior to speech intelligibility. As this rate 
drops below 100 – 120 wpm, speech intelligibility 
tends to decline rapidly (4,10). The diagnostic value 
of this measure for detecting disease onset, how-
ever, is questionable because even healthy individu-
als vary considerably in their habitual speaking 
rates (12) and are capable of using various strate-
gies (11) for maintaining this rate as oromotor 
strength declines (8). 
 Over the past several decades, a relatively small 
number of speech researchers have worked to 
develop selective measures of speech subsystem 
motor involvement (see (5)). These speech subsys-
tem measures are more sensitive than current best 
practices for detecting subclinical changes in bulbar 
motor performance. The extant work on these mea-
sures has, however, largely focused on the testing 
of a single speech subsystem (e.g. phonatory, artic-
ulatory, or resonatory) in populations with motor 
disorders other than ALS. The intent of this review 
is to integrate this disparate literature by 1) identi-
fying promising instrumental measures of speech 
subsystem performance; and 2) presenting prelimi-
nary fi ndings demonstrating the diagnostic poten-
tial of these measures relative to those currently 
used in translational research and clinical practice. 
The ultimate purpose of this research is to design 
a minimally invasive yet comprehensive bulbar 
motor assessment instrument that is readily adapt-
able to clinical settings, and intended for the mon-
itoring of disease progression and clinical trial 
application. 
 Framework for the assessment of bulbar impairment: 
a speech subsystem approach 
 Speech researchers traditionally include the bulbar 
system as part of the larger speech production net-
work, comprised of four distinct subsystems (13 – 15): 
respiratory, phonatory, articulatory, and resonatory 
(see Figure 1). In this review, we highlight several 
instrumental based measures that when combined, 
show promise for forming the basis of a comprehen-
sive, quantitative bulbar motor assessment in ALS. 
In addition, preliminary data are presented that 
demonstrate the feasibility of this approach. The 
applied goal of this instrument is to improve early 
detection of bulbar involvement and to provide a 
reproducible, quantitative index of change in the rate 
of bulbar progression. 
 Figure 1. The four speech subsystems. 
 The respiratory subsystem . ALS inevitably results in 
weakening of the respiratory musculature character-
ized by symptoms of dyspnea on exertion, ortho-
pnea, and early morning headaches with fatigue. 
Respiratory failure remains the leading cause of 
death (16). The average rate of decline in vital capac-
ity is reported to be 1.8% per month in patients with 
slowly progressive ALS and 3.5% per month in rap-
idly progressive disease (17,18). Although respira-
tory function is accurately documented through 
spirometry (19), the measured effects on speech 
communication remain poorly understood. Speech 
breathing patterns are quantifi ed using technologies 
that record chest wall movements, oral pressures and 
fl ows, and speech acoustics. The most extensively 
studied aspect of speech breathing decline in persons 
with ALS has been the patterns of pauses in acoustic 
recordings of connected speech (9,20). Because 
respiratory muscle weakness necessitates more fre-
quent inspirations during speech, persons with ALS 
exhibit longer and more frequent pauses than do 
healthy controls (20). 
 The phonatory subsystem. Perceptible changes in 
voice quality or loudness may be the fi rst symptom 
of bulbar involvement, even in spinal-onset disease 
(21,22). The consistent pattern of vocal fold 
vibration is a function of muscular tension, the vis-
coelastic properties of vocal fold tissue, and the air 
pressure and fl ow generated by the lungs (23). 
Because voice quality is affected by multiple factors, 
the assessment of the laryngeal subsystem requires 
evaluation of multiple voice variables. 
 Auditory perceptual (i.e. listening-based) judg-
ments of voice characteristics, including roughness, 
strain, breathiness, and loudness, are the most com-
mon measures of laryngeal involvement assessed 
by speech-language pathologists (24). Previous 
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studies have suggested more than 60% of all patients 
with ALS exhibit changes to vocal quality such as 
tremor, breathiness, and harshness (25). Recordings 
of voice acoustics and aerodynamics provide a 
more objective assessment of phonatory function 
than subjective judgments of voice quality, which 
requires special training and can be unreliable (26). 
In persons with ALS, phonatory function decline has 
been detected prior to speech decline using acoustic 
measures of voice (27). Although abnormal phona-
tory characteristics associated with ALS vary consid-
erably, phonatory dysfunction has been characterized 
as abnormal vocal pitch (too high or low), limited 
pitch range, instability of vocal fold vibration, and 
high noise-to-harmonic ratios (21,22,25,28 – 31). 
The latter measure quantifi es the amount of noise in 
the voice signal. 
 The resonatory subsystem . Velopharyngeal muscle 
weakness leads to continual opening of the velopha-
ryngeal port during speech. Acoustic energy then 
enters the nasal cavity producing abnormal nasal 
resonances. Consequently, speech becomes exces-
sively nasal (or hypernasal) with speech sounds 
becoming less distinct and weak in intensity. In 
severe cases of velopharyngeal incompetence, 
speech can be rendered unintelligible. Although 
velopharygeal function has rarely been investigated 
in ALS (e.g. (32)), the existing data suggest 
that hypernasality may be a defi ning characteristic 
of bulbar disease. Carrow et  al. (25) reported 
that 75% of the 79 patients they studied with motor 
neuron disease exhibited hypernasality. 
 Due to its inaccessibility, velopharygeal function-
ing is rarely studied directly. Aerodynamic or acous-
tic methods are traditionally used to detect spurious 
nasal airfl ow emissions or the presence of nasal res-
onances (see (33)). Nasalance, the relative propor-
tion of nasal to oral acoustic energy in speech, is 
widely used by speech-language pathologists to 
assess velopharyngeal function. Nasalance scores 
correlate well with listeners ’ perceptions of nasality 
due to ALS (32). The measure has been shown to 
be reliable (test-retest error    2%), and has a high 
specifi city (87% – 93%) and a high sensitivity (83% –
 97%) in persons with velopharyngeal incompetence 
due to cleft lip and palate (34,35). Delorey et  al. (32) 
reported signifi cant changes across a six-month 
interval in nasalance for groups of participants with 
bulbar and spinal deterioration due to ALS. The 
measure was able to differentiate the bulbar group 
from the spinal group and healthy controls at both 
recordings, with the bulbar group exhibiting greater 
nasalance scores than the other groups. 
 The articulatory subsystem . Testing of articulatory 
involvement is achieved through measures of oral 
movement and strength. Speech is the product of 
highly coordinated movements of the tongue, lips, 
and jaw. The small movements of the lips and jaw 
can be non-invasively recorded using computer-
based optical tracking systems (36). Magnetic 
(37,38) or imaging technologies such as dynamic 
MRI (39) and ultrasound (40) are currently 
required to capture the movements of the tongue 
inside the mouth. Multiple features of motor per-
formance can be evaluated from speech movement 
recordings including movement extent, speed, and 
acceleration (see (41)). Other variables often 
measured include the regularity of the movement 
patterns (42,43) and the temporal coordination 
between the movements of different articulators 
(36). 
 As ALS progresses, speech movements become 
smaller in extent, slower in speed and longer in 
duration (8,44 – 47). In some individuals, the longi-
tudinal course of decline is interrupted by a transient 
increase in movement extent and speed, particularly 
in the jaw (47,48). These studies also reported 
that the speed of speech movements was more con-
sistently affected in ALS than several other measur-
able speech variables. Movement speed may be a 
particularly sensitive index of early motor deteriora-
tion in ALS as the disease appears to selectively 
affect fast-twitch muscles, as noted in early phases 
of the motor neuron disease mouse model when the 
animal is presymptomatic (49,50). 
 The force generating capacities of the jaw, lips 
and tongue can be measured using either a strain 
gauge (51) or pneumatic pressure bulb (52). Static 
measures are intended to test force generating 
capacity (strength and endurance) and dynamic 
 Table I. Participant characteristics for the Control, ALS Normal Speech, and ALS Impaired Speech groups. The values for 
Gender and Onset are counts, and the values for all other variables are means (standard deviations). FVC refers to predicted forced 
vital capacity. 
Gender
Age (years)
Months 
since onset
Onset
ALSFRS-R 
Total
ALSFRS-R 
Bulbar FVC
Speech 
IntellGroup Male Female bulbar spinal
Healthy 
controls
4 6 60.10 (10.54)  –  –  –  –  – 3.00 (1.36) 98.71 (1.23)
ALS Normal 
Speech
6 4 55.69 (11.20) 57.30 (50.74) 2 ∗ 9 ∗ 33.00 (5.40) 10.00 (1.70) 2.67 (1.14) 99.73 (0.61)
ALS Impaired 
Speech
5 5 59.41 (11.79) 33.30 (21.35) 4 6 33.00 (9.29)  8.60 (1.71) 2.53 (1.13) 91.45 (3.64)
 ∗ Onset for one subject was both bulbar and spinal. 
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measures are intended to assess force regulation 
(motor control). The maximum force and peak 
rate of change of force in the tongue and lips are 
markedly reduced in ALS (6,53). The test-retest reli-
ability of oral strength measures varies across studies 
from moderate (54) to high (55). Common to all 
maximum performance assessments, oral strength 
scores are affected by age, gender, practice and moti-
vation (56). These factors may drive the large popu-
lation variance reported with these measures, limiting 
their usefulness in clinical trials (57). 
 Towards an objective bulbar assessment: 
preliminary data 
 Below we present preliminary data from an 
ongoing study of bulbar motor decline, demon-
strating the use of subsystem measures for the assess-
ment of bulbar disease onset and progression. The 
analyses were based on cross-sectional data from 30 
participants: 10 healthy controls and 20 participants 
with ALS. The participants with ALS were stratifi ed 
into two groups (10 participants per group) based 
on their speech intelligibility scores: ALS Normal 
Speech (100 – 97%) and ALS Impaired Speech 
(96 – 86%). Information about the characteristics of 
each participant group is provided in Table I. 
 The respiratory, phonatory and resonatory sub-
systems were evaluated using the methods described 
above and previously in Yunusova et  al. (5). The 
assessors were blinded to group assignment and 
ALS diagnosis. Table II shows the speech subsystem 
variables that were collected in addition to speech 
intelligibility (%), speaking rate (words per minute), 
and a bulbar severity score, which was derived 
by summing the scores from the three questions 
about speech, swallowing, and salivation on 
the Amyotrophic Lateral Sclerosis Functional Rating 
Scale-Revised (58 – 60). The mean values for each 
group and variable are displayed in Figure 2. All 
group differences were tested using  t- tests for inde-
pendent samples using an alpha level of .05. 
 Early detection of bulbar involvement . As displayed in 
Figure 2, statistically signifi cant differences were 
observed for speaking rate, lower lip, jaw, and 
tongue. The between-group effect sizes for these 
 Table II. Instrumentation-based speech subsystem variables recorded in this study. 
Speech subsystem Measure Experimental tasks
Respiratory Percent pause (%) Reading of Bamboo passage
Phonatory Noise to harmonic ratio Sustained  “ ah ” 
Resonatory Nasalance (%) Sentence repetition:  “ Buy Bobby a puppy ” 
Articulatory
Jaw Peak movement speed (mm/s) Word repetition:  “ uhpah ” 
Lip Peak movement speed (mm/s) Word repetition:  “ uhpah ” 
Tongue Peak movement speed (mm/s) Word repetition:  “ I owe you a yoyo today ” 
 Figure 2. The mean values and standard error for each group and variable. Statistically signifi cant comparisons are marked with 
horizontal brackets. 
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data are presented in Figure 3. For each speech 
system and subsystem measure, we computed the 
Cohen ’ s d effect sizes (expressed in absolute value) 
between healthy controls and persons in the ALS 
Normal Speech group. Based on Cohen ’ s conven-
tions (61), the observed effect sizes were large for 
the tongue, medium for lower lip and jaw, and small 
for speaking rate. The observation of early tongue 
signs is consistent with prior reports from studies 
of muscle strength and articulatory movements 
(6,40,42,62). 
 Changes during the mild to moderate phase of speech 
impairment . As displayed in Figure 2, statistically 
signifi cant differences were observed for speaking 
rate, ALSFRS-R bulbar subscore, lower lip, and 
tongue. It is notable that the lower lip movement 
speed was faster for the ALS Impaired Speech 
group than for the ALS Normal Speech Group and 
that jaw movement speed showed a similar trend. 
This unexpected increase in lip and jaw movement 
speed with disease progression is thought to be a 
compensatory response to the slowing of tongue 
movements (47,48). 
 For each speech system and subsystem measure, 
the Cohen ’ s d effect sizes (expressed in absolute 
value) between the ALS Normal Speech group 
and the ALS Impaired Speech group were also 
computed (Figure 4). Effect sizes were large for the 
lower lip and tongue speeds, and marginally large 
for speaking rate. 
 Conclusions 
 The reliable assessment of bulbar involvement in 
ALS continues to be a signifi cant clinical and research 
challenge. 
 Figure 3. Effect sizes for each speech variable representing the differences between the healthy controls and the ALS participants 
with normal speech intelligibly. Statistically signifi cant comparisons are marked with asterisks. 
 Figure 4. Effect sizes for each speech variable representing the differences between participants with ALS who had normal 
speech and who had impaired speech. Statistically signifi cant comparisons are marked with asterisks. 
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 Overall, our preliminary fi ndings suggest that 
measures of speech motor performance, in particular 
tongue movement speed, may be well suited for both 
early detection and progress monitoring. Speaking 
rate was also an effective measure for both early 
detection and progress monitoring, but was only 
associated with mild to moderate effect sizes. The 
ALSFRS-R bulbar subscore and several of the speech 
subsystem measures did not detect differences 
among the groups in this sample. 
 Longitudinal studies with a larger pool of par-
ticipants are required to further interrogate the 
clinical effi cacy of different bulbar measures, 
which should include determining each measure ’ s 
psychometric properties (e.g. reliability, validity, 
specifi city, sensitivity). Additional work also is needed 
to address barriers to clinical implementation includ-
ing high equipment cost, equipment complexity, 
and the burden of data reduction. These issues are 
being actively investigated by multidisciplinary 
research teams focused on developing improved 
speech movement tracking hardware and intelligent 
algorithms to identify abnormal speech and voice 
patterns in large datasets (64). 
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